Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Human Genome Sciences    HGSI

SummaryQuotesNewsCompany 
News SummaryMost relevantAll newsSector news 

Human Genome Holder Says Glaxo Bid "Unacceptable" - Newspaper

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/29/2012 | 03:22pm CET

A fund with a 5.6% stake in Human Genome Sciences Inc. (>> Human Genome Sciences), the U.S. drug company for which GlaxoSmithKline PLC (>> GlaxoSmithKline plc) has made an unsolicited $2.6 billion offer, said the approach is "unacceptable", according to the Sunday Times.

Human Genome Sciences, based in Rockville, Md., on April 20 rejected Glaxo's $13 a share offer, which it said undervalues the company.

Taube Hodson Stonex, a London-based fund, said the offer amounted to Glaxo trying to "get a steal with an offer that completely undervalues the company", the Sunday Times reports, attributing the remarks to Taube Hodson Stonex's Mark Evans.

"Towards $20 per share would still feel undervalued," Evans is quoted as saying.

THS couldn't be reached for comment Sunday.

Glaxo and Human Genome Sciences have a long working relationship, co-leveloping and sharing profits on Benlysta, a lupus medicine.

Newspaper Web site: http://www.timesonline.co.uk

-London Bureau, Dow Jones Newswires; +44 (0)20 7842 9320

Stocks mentioned in the article : Human Genome Sciences, GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HUMAN GENOME SCIENCES
2012 HUMAN GENOME SCIENCES : Announces required offer to repurchase in respect of its..
2012DJGlaxoSmithKline Completes Acquisition of Human Genome Sciences
2012DJGlaxoSmithKline Gets 79% Tenders for Human Genome Sciences Offer
2012 EXCLUSIVE : Human Genome rejected Amgen's $7 billion bid in 2010: sources
2012 HUMAN GENOME SCIENCES : Securities Lawyers at Goldfarb LLP Seeking More Money, I..
2012 HUMAN GENOME SCIENCES : Law Offices of Howard G. Smith Announces Investigation o..
2012 HUMAN GENOME SCIENCES : Law Office of Brodsky & Smith, LLC Announces Investigati..
2012 HUMAN GENOME SCIENCES : Inc. Board of Directors Under Investigation for Potentia..
2012 HUMAN GENOME SCIENCES : Ryan & Maniskas, LLP Announces Investigation of Human Ge..
2012 HUMAN GENOME SCIENCES : Robbins Umeda LLP Announces an Investigation of Human Ge..
More news
Sector news : Biotechnology & Medical Research - NEC
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Sector and Competitors
1st jan.Capitalization (M$)
HUMAN GENOME SCIENCES0.00%0
INCYTE CORPORATION-5.93%19 735
QUINTILES IMS HOLDINGS..7.82%18 636
CELLTRION, INC.--.--%9 979
SEATTLE GENETICS, INC.48.62%9 379
LONZA GROUP AG8.34%9 293
More Results